- Support patients with an impaired immune response.
- Clinically trialled AHCC™ with an extensive safety and tolerance profile.
- Contains ginger to address nausea, vomiting and appetite; and to protect intestinal mucosa.
Clinical benefits:
- Immunogenics supports patients with an impaired immune response, assisting with immune system surveillance and modulation.
- Research into AHCC™ reveals positive effects on both innate and adaptive immunity.
- AHCC™ is well tolerated, making it suitable as an adjunct for immunosuppressed patients during and in between treatments to reduce possible side effects.
- Ginger assists with nausea, vomiting, gut barrier function, and also exerts anti-ulcer, anti-inflammatory and immunomodulatory effects.
- Immunogenics has been formulated to match the amount of
AHCC™ used in human clinical trials. - AHCC™ is a mixture of amino acids, lipids and minerals extracted from a culture of shiitake mushroom, with polysaccharides being an active component.
